1. Home
  2. CRI vs TRVI Comparison

CRI vs TRVI Comparison

Compare CRI & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$36.84

Market Cap

1.2B

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$11.50

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRI
TRVI
Founded
1865
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2003
2019

Fundamental Metrics

Financial Performance
Metric
CRI
TRVI
Price
$36.84
$11.50
Analyst Decision
Hold
Strong Buy
Analyst Count
5
12
Target Price
$32.60
$20.38
AVG Volume (30 Days)
1.3M
1.5M
Earning Date
02-24-2026
03-17-2026
Dividend Yield
2.72%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
$2,832,687,000.00
N/A
Revenue This Year
$2.49
N/A
Revenue Next Year
$0.10
N/A
P/E Ratio
$15.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.38
$3.77
52 Week High
$54.58
$14.39

Technical Indicators

Market Signals
Indicator
CRI
TRVI
Relative Strength Index (RSI) 62.13 52.65
Support Level $32.24 $10.72
Resistance Level $38.88 $11.93
Average True Range (ATR) 1.67 0.72
MACD 0.20 0.14
Stochastic Oscillator 85.89 76.63

Price Performance

Historical Comparison
CRI
TRVI

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Share on Social Networks: